Abstract
Amorphous materials have always been an essential part of pharmaceutical research They are important because of their characteristic solubility characteristics, common occurrence, and physicochemical instability relative to corresponding crystals. Some pharmaceutical agents have a tendency to exist as amorphous solids, while others require prevention of their crystallization to remain in the amorphous state in order to achieve desire characteristics. Amorphous solids can be stabilized by some common pharmaceutical processes like solid dispersion technique, solvent evaporation, milling, lipid dispersion. This article reviews the methodologies and approaches for stabilization of amorphous form.
Keywords: Amorphous solid, crystallization, dispersion techniques, milling, physicochemical instability, stabilization
Current Drug Therapy
Title:Approaches to Stabilize Amorphous Form - A Review
Volume: 7 Issue: 4
Author(s): Kisan R. Jadhav, Sharad S. Pacharane, Priti P. Pednekar, Praveen V. Koshy and Vilasrao J. Kadam
Affiliation:
Keywords: Amorphous solid, crystallization, dispersion techniques, milling, physicochemical instability, stabilization
Abstract: Amorphous materials have always been an essential part of pharmaceutical research They are important because of their characteristic solubility characteristics, common occurrence, and physicochemical instability relative to corresponding crystals. Some pharmaceutical agents have a tendency to exist as amorphous solids, while others require prevention of their crystallization to remain in the amorphous state in order to achieve desire characteristics. Amorphous solids can be stabilized by some common pharmaceutical processes like solid dispersion technique, solvent evaporation, milling, lipid dispersion. This article reviews the methodologies and approaches for stabilization of amorphous form.
Export Options
About this article
Cite this article as:
R. Jadhav Kisan, S. Pacharane Sharad, P. Pednekar Priti, V. Koshy Praveen and J. Kadam Vilasrao, Approaches to Stabilize Amorphous Form - A Review, Current Drug Therapy 2012; 7 (4) . https://dx.doi.org/10.2174/157488512804999118
DOI https://dx.doi.org/10.2174/157488512804999118 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting the Kinetochore in Cancer Therapy: The Ndc80/Hec1 Complex
Current Drug Therapy Puerarin: A Review on the Pharmacological Activity, Chemical Properties and Pharmacokinetics of Main Isoflavonoid
The Natural Products Journal Drug Trials in Dementia: Challenging Ethical Dilemmas
Current Alzheimer Research Possible Role of BDNF-Induced Microglial Intracellular Ca<sup>2+</sup> Elevation in the Pathophysiology of Neuropsychiatric Disorders
Mini-Reviews in Medicinal Chemistry The Selective Serotonin Reuptake Inhibitor Paroxetine, but not Fluvoxamine, Decreases Methamphetamine Conditioned Place Preference in Mice
Current Neuropharmacology Insights Into the Molecular Aspects of Neuroprotective Bacoside A and Bacopaside I
Current Neuropharmacology Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Unique Coronary Artery Disease Differences in Women as Related to Revascularization
Current Medicinal Chemistry Comparative Analysis of Spouse’s Burden and Quality of Life in Major Depressive Disorder and Bipolar I Disorder
Current Psychiatry Research and Reviews Oncogenic MicroRNAs in the Genesis of Leukemia and Lymphoma
Current Pharmaceutical Design Behavioral Pharmacology of Cannabinoids with a Focus on Preclinical Models for Studying Reinforcing and Dependence-Producing Properties
Current Drug Abuse Reviews Peptides for Therapy and Diagnosis of Alzheimer's Disease
Current Pharmaceutical Design Photochemical Degradation of Hyperforin
Letters in Organic Chemistry Do Human Lipoxygenases have a PDZ Regulatory Domain?
Current Molecular Medicine The Crosstalk of RAS with the TGF-β Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy
Current Cancer Drug Targets Current Neuropharmacology Volume 9, Supplement 1, September 2011
Current Neuropharmacology Cognitive and Functional Influences of Vildagliptin, a DPP-4 Inhibitor, Added to Ongoing Metformin Therapy in Elderly with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Substrates, Inhibitors and Activators of P-glycoprotein: Candidates for Radiolabeling and Imaging Perspectives
Current Topics in Medicinal Chemistry Origins, Controversies and Recent Developments of the MCI Construct
Current Alzheimer Research Aetiology, Diagnosis and Treatment of Hydrops Foetalis
Current Pediatric Reviews